Discriminating signal from noise: the biological variation of circulating calprotectin in serum and plasma-Reference-Cited by-同舟云学术

Discriminating signal from noise: the biological variation of circulating calprotectin in serum and plasma

Published:2023-12-12 Issue:0 Volume:0 Page:
ISSN:1434-6621
Container-title:Clinical Chemistry and Laboratory Medicine (CCLM)
language:en
Short-container-title:

Author:

Briers Marth¹²,Massa Bo¹²^ORCID,Vander Cruyssen Bert³,Van Den Bremt Stefanie¹,Hofman Laura¹,Van Langenhove Leen⁴,Hoermann Bernhard⁵^ORCID,Bossuyt Xavier²⁶^ORCID,Van Hoovels Lieve¹⁶^ORCID

Affiliation:

1. Department of Laboratory Medicine , OLV Hospital , Aalst , Belgium

2. Department of Laboratory Medicine , University Hospital Leuven , Leuven , Belgium

3. Department of Rheumatology , OLV Hospital , Aalst , Belgium

4. I-BioStat, KU Leuven , Leuven , Belgium

5. Thermo Fisher Scientific , Freiburg , Germany

6. Department of Microbiology, Immunology and Transplantation , KU Leuven , Leuven , Belgium

Publisher

Walter de Gruyter GmbH

Subject

Biochemistry (medical),Clinical Biochemistry,General Medicine

Link

https://www.degruyter.com/document/doi/10.1515/cclm-2023-1126/pdf

Reference10 articles.

1. Manfredi, M, Van Hoovels, L, Benucci, M, De Luca, R, Coccia, C, Bernardini, P, et al.. Circulating calprotectin (cCLP) in autoimmune diseases. Autoimmun Rev 2023;22:103295. https://doi.org/10.1016/j.autrev.2023.103295.

2. Choi, IY, Gerlag, DM, Herenius, MJ, Thurlings, RM, Wijbrandts, CA, Foell, D, et al.. MRP8/14 serum levels as a strong predictor of response to biological treatments in patients with rheumatoid arthritis. Ann Rheum Dis 2015;74:499–505. https://doi.org/10.1136/annrheumdis-2013-203923.

3. Nordal, HH, Brokstad, KA, Solheim, M, Halse, AK, Kvien, TK, Hammer, HB. Calprotectin (S100A8/A9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. Arthritis Res Ther 2017;19:3. https://doi.org/10.1186/s13075-016-1201-0.

4. Andres Cerezo, L, Mann, H, Pecha, O, Plestilova, L, Pavelka, K, Vencovsky, J, et al.. Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 2011;13:R122. https://doi.org/10.1186/ar3426.

5. Hurnakova, J, Hulejova, H, Zavada, J, Komarc, M, Hanova, P, Klein, M, et al.. Serum calprotectin discriminates subclinical disease activity from ultrasound-defined remission in patients with rheumatoid arthritis in clinical remission. PLoS One 2016;11:e0165498. https://doi.org/10.1371/journal.pone.0165498.